Neurology India
Open access journal indexed with Index Medicus
  Users online: 58  
 Home | Login 
  About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe Etcetera Contact  
  Navigate Here 
 »   Next article
 »   Previous article
 »   Table of Contents

 Resource Links
 »   Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
 »Related articles
 »   Citation Manager
 »   Access Statistics
 »   Reader Comments
 »   Email Alert *
 »   Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed2229    
    Printed80    
    Emailed1    
    PDF Downloaded105    
    Comments [Add]    
    Cited by others 2    

Recommend this journal

 

 ORIGINAL ARTICLE
Year : 2011  |  Volume : 59  |  Issue : 6  |  Page : 803--809

Identification of deletions and duplications in the Duchenne muscular dystrophy gene and female carrier status in western India using combined methods of multiplex polymerase chain reaction and multiplex ligation-dependent probe amplification


1 Department of Molecular Biology, Institute for Advanced Training and Research in Interdisciplinary Sciences (IATRIS), Therapeutic Drug Monitoring Laboratory, Sion, India
2 Department of Neurology, Medical Research Centre, Bombay Hospital, Mumbai, India
3 Department of Human Genetics, Emory School of Medicine, Atlanta, USA

Correspondence Address:
Rashna S Dastur
Department of Molecular Biology, Institute for Advanced Training & Reserch in Interdisciplinary Sciences (IATRIS), (TDM-Therapeutic Drug Monitoring Laboratory), Plot 194, Scheme No. 6, Road No. 15, Sion-Koliwada, Sion (East), Mumbai - 400 022
India
Login to access the Email id


DOI: 10.4103/0028-3886.91355

Get Permissions

Background: The technique of multiplex ligation-dependent probe amplification (MLPA) assay is an advanced technique to identify deletions and duplications of all the 79 exons of DMD gene in patients with Duchenne/Becker muscular dystrophy (DMD/BMD) and female carriers. Aim: To use MLPA assay to detect deletions which remained unidentified on multiplex polymerase chain reaction (mPCR) analysis, scanning 32 exons of the "hot spot" region. Besides knowing the deletions and/or duplications, MLPA was also used to determine the carrier status of the females at risk. Materials and Methods: Twenty male patients showing no deletions on mPCR and 10 suspected carrier females were studied by MLPA assay using P-034 and P-035, probe sets (MRC Holland) covering all the 79 exons followed by capillary electrophoresis on sequencing system. Results: On MLPA analysis, nine patients showed deletions of exons other than 32 exons screened by mPCR represented by absence of peak. Value of peak areas were double or more in four patients indicating duplications of exons. Carrier status was confirmed in 50% of females at risk. Conclusion: Combining the two techniques, mPCR followed by MLPA assay, has enabled more accurate detection and extent of deletions and duplications which otherwise would have remained unidentified, thereby increasing the mutation pick up rate. These findings have also allowed prediction of expected phenotype. Determining carrier status has a considerable significance in estimating the risk in future pregnancies and prenatal testing options to limit the birth of affected individuals.






[FULL TEXT] [PDF]*


        
Print this article     Email this article

Online since 20th March '04
Published by Medknow